
CAS: 1007223-17-7
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
![]() | Olokizumab REF: TM-T76753CAS: 1007223-17-7 | 95% - 95% | 240.00 €~1,681.00 € | Fri 28 Mar 25 |
![]() | Olokizumab REF: 3D-CLA1257CAS: 1007223-17-7 | - - - | To inquire | Mon 07 Apr 25 |

Olokizumab
CAS:1007223-17-7
Revdofilimab (ABBV-368) is a human IgG monoclonal antibody targeting OX 40 with potential anticancer activity.
Purity:
95% - 95%
Color and Shape:
Liquid
Ref: TM-T76753
1mg | 240.00 € | ||
5mg | 620.00 € | ||
10mg | 845.00 € | ||
25mg | 1,225.00 € | ||
50mg | 1,681.00 € |
Estimated delivery in United States, on Friday 28 Mar 2025

Ref: 3D-CLA1257
Undefined size | To inquire |
Estimated delivery in United States, on Monday 7 Apr 2025